ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Anti-Thymocyte Globulin Promotes Tfh Cells Differentiation and Alloantibody Production

R. Benedetti Gassen, B. Aoyama, M. Lima, T. Borges, M. Pérez-Sáez, N. Murakami, P. Sage, J. Pascual, L. V. Riella

Transplantation Research Center, Brigham and Women's Hospital, Boston, MA

Meeting: 2020 American Transplant Congress

Abstract number: 542

Keywords: Antibodies, B cells, Heart/lung transplantation, T helper cells

Session Information

Date: Saturday, May 30, 2020

Session Name: B-cells / Antibodies /Autoimmunity

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:39pm-3:51pm

Location: Virtual

Related Abstracts
  • IL-1β and IL-6 Facilitate T Cell Reconstitution in Heart Allograft Recipients Treated with Anti-Thymocyte Globulin
  • CD40-Dependent Help by CD4 T Cells Is Required for CD8 T Cell Recovery after Antithymocyte Globulin Lymphoablation

*Purpose: Antibody-mediated rejection is a major cause of long-term graft loss. T follicular helper (Tfh) cell is CD4+ T cell subset that is specialized in providing help for germinal center (GC) reactions where B cells are activated, differentiate and produce high-affinity antibodies. Anti-thymocyte globulin (ATG) is a widely used lymphocyte-depleting induction therapy, however, little is known about how ATG affects Tfh development and DSA formation.

*Methods: To study the effect of ATG on Tfh, we developed mouse ATG (mATG) by immunizing rabbit with mouse thymocytes and tested mATG in a fully MHC allogeneic transplant model and in a NP-Ova/CFA immunization model. In the latter, we immunized mice with NP-Ova (100 mcg/mouse, s.c.) and CFA on day 0, and received IgG control or mATG (500 mcg/mouse, i.p.) on day 0 and day 4. We also analyzed PBMCs for Tfh frequency in transplant recipients that had received ATG vs. no-ATG as induction.

*Results: We observed higher circulating Tfh (cTfh) in transplant patients treated with ATG. In mice, mATG effectively depleted the peripheral CD4+ and CD8+ T cells in spleen, lymph nodes (LNs) and peripheral blood in naïve mice. Depletion was less effective in Tfh and Treg cells. In full HLA-mismatch cardiac transplant model, mATG treated group had higher percentage of Tfh in peripheral blood, consistent with human data. To dissect the exact mechanism of higher percentage of remaining Tfh, we used NP-Ova/CFA immunization model. mATG-treated group had higher percentage of Tfh cells (CD4+CXCR5+PD-1+) (Fig.1 B), GC B cells (B220+Fas+GL7+) (Fig.1 C), and higher titer of NP-specific antibody (Fig.1 C) compared to controls. We also evaluated other CD4+ T cells subpopulations by staining for transcriptor factors T-Bet (Th1 cells), GATA3 (Th2 cells), RORyT (Th17 cells), Foxp3 (T regulatory cells) and the dominant difference were in Bcl-6 (Tfh cells) in all tissues analyzed (Fig.1 D). Lastly, the Bcl-6 repressor cytokine IL-2 was decreased 6h after the ATG administration in serum (Fig.1 E). This suggests that less IL-2 availability caused by mATG creates favorable environment for Tfh differentiation

*Conclusions: mATG is effective in depleting T cells. However, the remaining CD4+ T cells are mostly Tfh cells. Lower IL-2 appears to favor Tfh cells differentiation, although the mechanisms require further investigation. Since antibody-mediated rejection is a dominant cause of graft failure, investigating the mechanism of this resistance is crucial for the development of more effective therapies in restraining Tfh cells.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gassen RBenedetti, Aoyama B, Lima M, Borges T, Pérez-Sáez M, Murakami N, Sage P, Pascual J, Riella LV. Anti-Thymocyte Globulin Promotes Tfh Cells Differentiation and Alloantibody Production [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/anti-thymocyte-globulin-promotes-tfh-cells-differentiation-and-alloantibody-production/. Accessed February 28, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.